Evidence map›Paper›PMID 20700111›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011

Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.

Raouia Fakhfakh, Annick Michaud, Jacques P Tremblay

Open access · hybridAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. CRISPR/Cas9-TargetedJournal of developmental biology · 2025
    Article
  4. Review
  5. Article
  6. Skeletal muscle cell transplantation: models and methods.Journal of muscle research and cell motility · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pharmacology of manipulating lean body mass.Clinical and experimental pharmacology & physiology · 2015
    Review
  15. Knockdown of endogenous myostatin promotes sheep myoblast proliferation.In vitro cellular & developmental biology. Animal · 2014
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Raouia FakhfakhUnité de recherche en Génétique Humaine, Centre de recherche de CHUL, CHUQ, Faculté de médecine, Université Laval, Sainte-Foy, Québec, Canada.
Annick Michaud
Jacques P Tremblay
Université Laval · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is a recessive disease caused by a dystrophin gene mutation. Myoblast transplantation permits to introduce the dystrophin gene in dystrophic muscle fibers. However, the success of this approach is reduced by the short duration of the regeneration following the transplantation, which reduces the number of hybrid fibers. Myostatin (MSTN) is a negative regulator of skeletal muscle development and responsible for limiting regeneration. It binds with high affinity to the activin type IIB receptor (ActRIIB). Our aim was to verify whether the success of the myoblast transplantation is enhanced by blocking the MSTN signal with expression of a dominant negative mutant of ActRIIB (dnActRIIB). In vitro, blocking MSTN activity with a lentivirus carrying dnActRIIB increased proliferation and fusion of human myoblasts because MSTN regulates the expression of several myogenic regulatory factors. In vivo, myoblasts infected with the dnActRIIB lentivirus were transplanted in immunodeficient dystrophic mice. Dystrophin immunostaining of tibialis anterior (TA) cross-sections of these mice 1 month post-transplantation revealed more human dystrophin-positive myofibers following the transplantation of dnActRIIB myoblasts than of control myoblasts. Thus, blocking the MSTN signal with dnActRIIB improved the success of myoblast transplantation by increasing the myoblast proliferation and fusion and changed the expression of myogenic regulatory factors.

Indexed as

Activin Receptors, Type IIAnimalsCell FusionCell ProliferationDystrophinHumansLentivirusMiceMice, Inbred C57BLMice, Inbred mdxMuscle Fibers, SkeletalMuscular Dystrophy, AnimalMyoblastsMyoD ProteinMyogenic Regulatory FactorsMyostatinActivin Receptors, Type IIactivin receptor type II-ADystrophinMyoD1 myogenic differentiation proteinMyoD ProteinMyogenic Regulatory FactorsMyostatin

Identifiers

PMID20700111
PMCPMC3017433
OpenAlexW1971744331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.